A randomised controlled trial of point-of-care cardiac markers in the emergency department

niversity of Sheffield (UK)0 个研究点目标入组 3,130 人开始时间: 2007年2月1日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•People presenting to the Emergency Department with chest pain due to suspected but not proven Acute Myocardial Infarction (AMI) in whom a negative point-of-care marker test could potentially rule out AMI and allow discharge home.

•1. Patients with diagnostic Electrocardiogram (ECG) changes for AMI or high-risk acute coronary syndrome (more than 1 mm ST deviation or more than 3 mm inverted T waves). These patients are at high risk of adverse outcome and require inpatient care even if marker tests are negative
•2. Patients with known coronary heart disease presenting with prolonged (more than one hour) or recurrent episodes of typical cardiac-type pain. These patients have unstable angina and require inpatient care for symptom control even if marker tests are negative
•3. Patients with proven or suspected serious non-coronary pathology (e.g. pulmonary embolus) that requires inpatient care even if AMI is ruled out
•4. Patients with co-morbidity or social problems that require hospital admission even if AMI can be ruled out
•5. Patients with an obvious non-cardiac cause (e.g. pneumothorax or muscular pain), in whom AMI can be excluded as a possible cause without resorting to further diagnostic testing
•6. Patients presenting more than 12 hours after their most significant episode of pain, for whom a single troponin measurement would clearly be more appropriate than point-of-care panel testing
•7. Previous participants in the RATPAC trial
•8. Patients who are unable to understand the trial information due to cognitive impairment
•9. Non-English speaking patients for whom translation facilities are not available

发起方

niversity of Sheffield (UK)